Skip to main content
Caplight Logo









ORF Genetics

ORF Genetics

Private
IcelandHealthcare & Life Scienceshttps://www.orfgenetics.com/

Last Round

VC Round

Sep 10, 2025

Total Funding Raised

$2.95M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

ORF Genetics is a biotechnology company that develops and manufactures recombinant proteins, such as growth factors, in bioengineered barley plants for use in stem cell research, regenerative medicine, cultivated meat, and skincare.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

recombinant proteinsgrowth factorsmolecular farminganimal-free growth factorscultivated meatbarley expression systemcellular agriculturelab grown meatstem cell researchplant-made proteinsendotoxin-free proteinsregenerative medicinecytokinescell culture mediabiomanufacturingancillary materialsskincare ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ORF Genetics Comparables

Compare ORF Genetics with similar companies based on industry and business-model similarity.

ORF Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Biotech
86%
Core Biogenesis
85%
Ventria Bioscience
83%

ORF Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 10, 2025
GrantAug 1, 2020

Key People

Founding team and executive leadership

Berglind Ran Olafsdottir

CEO

Executive Team

ORF Genetics Investors

Notable investors and investment history

ORF Genetics investors
InvestorRounds
European CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 266% MoM.

  • May 2, 2025

    Monthly visitors grew 206% MoM, from 392 to 1.2K.

ORF Genetics Filings

Explore SEC and related filing metadata, where available.

ORF Genetics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ORF Genetics's valuation, stock price, and market status.

Is ORF Genetics a public or private company?

ORF Genetics is a private company.

What is the current stock price of ORF Genetics?

ORF Genetics is a private company with no public stock price. No recent secondary market data is available.

How much is ORF Genetics worth (valuation)?

Valuation information for ORF Genetics is not publicly available.

Can I buy ORF Genetics stock?

ORF Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ORF Genetics's last funding round?

Funding round information for ORF Genetics is not publicly available.

Who are the main investors in ORF Genetics?

Investor information for ORF Genetics is not publicly disclosed.

Will ORF Genetics IPO soon?

No public IPO plans have been announced for ORF Genetics.

How can I track ORF Genetics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ORF Genetics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIceland
Employee Range18
Year Founded2001
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?